Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06712602 · ClinicalTrials.gov registry record · Phase 1
PT150 Drug for Use in Alcohol Use Disorder
A Phase 1 study of Alcohol Use Disorder, sponsored by Pop Test Oncology.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT06712602: Recruiting Phase 1 study of Alcohol Use Disorder, sponsored by Pop Test Oncology.
NCT06712602 is a Phase 1 study of Alcohol Use Disorder that is actively recruiting participants, run by Pop Test Oncology. The registered enrollment target is 34 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06712602, a Phase 1 study of Alcohol Use Disorder, is actively recruiting participants, sponsored by Pop Test Oncology.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn if PT150 can reduce the behavioral and physical effects of stress, alcohol, and alcohol use in people with alcohol use disorder.
Primary Outcome
Salivatory samples will be collected before and periodically after the alcohol challenge procedure for 120 minutes using cotton swab salivettes.
Conditions Studied
Interventions
- DRUG alcohol
- BEHAVIORAL Stress-Induction
- DRUG PT150
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2028-07-31 |
| Phase | Phase 1 |
What NCT06712602 shows while recruiting
NCT06712602 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which alcohol is the first listed.
NCT06712602 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06712602 about?
NCT06712602 is a clinical study titled "PT150 Drug for Use in Alcohol Use Disorder". The goal of this study is to learn if PT150 can reduce the behavioral and physical effects of stress, alcohol, and alcohol use in people with alcohol use disorder.
What is the current status of trial NCT06712602?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2025-02-01. Estimated completion is 2028-07-31.
What conditions does trial NCT06712602 study?
This clinical trial studies the following conditions: Alcohol Use Disorder.
What interventions are being tested in trial NCT06712602?
The interventions under investigation include: alcohol (DRUG), Stress-Induction (BEHAVIORAL), PT150 (DRUG).
Who is sponsoring clinical trial NCT06712602?
This trial is sponsored by Pop Test Oncology, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06712602 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06712602's enrollment target sits among peer trials
34 149th of 184 higher than 36 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intranasal Insulin for Treatment of Alcohol Use Disorder
RECRUITING · Phase 1
-
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
RECRUITING · Phase 1
-
Environment and Alcohol: A Pilot Study
RECRUITING · Phase 1
-
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
RECRUITING · Phase 1
-
Sex Differences in the Response to Abstinence From Alcohol.
RECRUITING · Phase 1
-
Spironolactone in Alcohol Use Disorder (SAUD)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI